Cargando…

Immunological targets for cancer therapy: new recognition

Detalles Bibliográficos
Autor principal: Shurin, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254540/
https://www.ncbi.nlm.nih.gov/pubmed/30538966
http://dx.doi.org/10.2147/ITT.S191821
_version_ 1783373737946513408
author Shurin, Michael R
author_facet Shurin, Michael R
author_sort Shurin, Michael R
collection PubMed
description
format Online
Article
Text
id pubmed-6254540
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62545402018-12-11 Immunological targets for cancer therapy: new recognition Shurin, Michael R Immunotargets Ther Editorial Dove Medical Press 2018-11-21 /pmc/articles/PMC6254540/ /pubmed/30538966 http://dx.doi.org/10.2147/ITT.S191821 Text en © 2018 Shurin. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Editorial
Shurin, Michael R
Immunological targets for cancer therapy: new recognition
title Immunological targets for cancer therapy: new recognition
title_full Immunological targets for cancer therapy: new recognition
title_fullStr Immunological targets for cancer therapy: new recognition
title_full_unstemmed Immunological targets for cancer therapy: new recognition
title_short Immunological targets for cancer therapy: new recognition
title_sort immunological targets for cancer therapy: new recognition
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254540/
https://www.ncbi.nlm.nih.gov/pubmed/30538966
http://dx.doi.org/10.2147/ITT.S191821
work_keys_str_mv AT shurinmichaelr immunologicaltargetsforcancertherapynewrecognition